The breast biopsy device market
is expected to reach USD 911.2 million by 2024, according to a new report by
Grand View Research, Inc. The Breast biopsy device market is projected to grow
at a productive rate in the next few years. The key factors supporting the
industry’s growth involve the rising awareness levels with regard to diagnostic
procedures through cancer screening programs, global rise in breast cancers in
women, and the high demand for less-invasive procedures. However, the degree of
risk is directly proportional to the extent of procedure invasiveness. Biopsy
causes pain and is a stressful procedure for patients, moreover, approximately
60% to 80% of breast biopsies in women result in a benign judgment. Therefore,
women are encouraged to consult experts for a second opinion before undergoing
a biopsy procedure, which is likely to hinder the growth of the market.
The test type segment is
categorized into needle breast biopsies and open surgical biopsies. The former
is further segmented into fine-needle aspiration, core-needle, and
vacuum-assisted core biopsy. The fine-needle aspiration segment is estimated to
hold the largest share for the year 2015 whereas the vacuum-assisted core
biopsy segment is anticipated to witness a lucrative growth during the study
period. The open surgical biopsy industry is sub-segmented into Incisional
biopsy and Excisional biopsy.
On the basis of products, the
industry is categorized into needles, tables, localization wires, and guidance
systems. Additionally, the guidance systems segment of the industry is further
categorized on the basis of imaging systems, such as ultrasound, mammography,
and magnetic resonance imaging.
In depth research report on Breast Biopsy Device Market
Further key findings from the study suggest:
·
The Asia Pacific region is
anticipated to witness the highest growth rate, with a CAGR of around 12.6%
during the forecast period. The high frequencies of breast cancer prevailing in
women as well as the increase in awareness of cancer screening programs are the
factors fueling the market growth.
·
North America accounts for the
largest market share, followed by the European market. The heightened awareness
about breast cancer that advocate regular checkups and screening programs along
with the demand for accurate and minimally caustic procedures are factors that
are responsible for the rapid market growth.
·
The mammography-guided
stereotactic segment is estimated to hold the largest market share followed by
the magnetic resonance imaging-guided category. The rise in demand for rapid
and precise diagnostic imaging tools in determining the exact location of the
tumor or lump in the breast area is one of the major factors driving the growth
of this industry
·
On the basis of test type, the
needle-based biopsy segment accounts for the largest share; this is mainly due
to the high demand for minimally invasive procedures. On the other hand, the
open surgical biopsies have a probability to witness a decline in the market
over the next few years due to the relatively high invasiveness and the risks
involved with the procedure.
·
Some major players in this
industry include Becton, Dickenson and Company (BD),C.R Bard, Inc., Devicor
medical, Inc., and Hologic, Inc., among others.
Grand View Research has
segmented the global breast biopsy devices market on the basis of test type,
guidance, product, and region:
Breast Biopsy Devices Market By Test Type Outlook
(Revenue, USD Million, 2013 - 2024)
·
Needle breast biopsies
·
Fine-needle aspiration
·
Core-needle aspiration
·
Vacuum-assisted core biopsy
·
Open surgical biopsies
·
Incisional breast biopsy
·
Excisional breast biopsy
Breast Biopsy Devices Market By Product Outlook (Revenue,
USD Million, 2013 - 2024)
·
Biopsy needles
·
Biopsy tables
·
Localization wires
·
Guidance systems
·
Others
Breast Biopsy Devices Market By Guidance Type Outlook
(Revenue, USD Million, 2013 - 2024)
·
Ultrasound-guided
·
Mammography-guided stereotactic
·
Magnetic resonance-guided
·
Others
Breast biopsy device market Regional Outlook (Revenue, USD
Million, 2013 - 2024)
·
North America
·
U.S.
·
Canada
·
Europe
·
Germany
·
U.K.
·
Asia Pacific
·
China
·
India
·
Latin America
·
Brazil
·
Mexico
·
Middle East and Africa
·
South Africa
Browse more research
reports of this category:
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting
company, registered in the State of California and headquartered in San
Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, the company offers market intelligence studies ensuring
relevant and fact-based research across a range of industries including
technology, chemicals, materials, healthcare and energy.
No comments:
Post a Comment